-
srdrplus.ahrq.gov/published_projects?page=11
October 25, 2022 - The AREDS 2 trial found the AREDS formulation with beta carotene associated with increased risk of lung … beta carotene when current smokers were excluded from the analysis (2.0% vs. 0.9%, p=0.04); almost all lung … The AREDS 2 trial found the AREDS formulation with beta carotene associated with increased risk of lung … beta carotene when current smokers were excluded from the analysis (2.0% vs. 0.9%, p=0.04); almost all lung
-
srdrplus.ahrq.gov/published_projects?page=26
June 27, 2021 - as add-on to ICS reduces the risk of exacerbations requiring systemic corticosteroids and improves lung … Triple therapy of ICS, LAMA, and LABA improves lung function measured through spirometry, although the
-
srdrplus.ahrq.gov/published_projects?page=18
October 06, 2021 - treatment, with or without systemic therapy for adults with brain metastases due to non-small cell lung
-
srdrplus.ahrq.gov/published_projects?page=9
January 17, 2023 - delivery and uptake of targeted preventive services (e.g., smoking cessation, recommended immunizations, lung … Only three included trials reported on smoking cessation, vaccination, or lung cancer screening outcomes
-
srdrplus.ahrq.gov/published_projects?page=51
June 23, 2021 - READ MORE Published on June 23, 2021 Imaging for the Pretreatment Staging of Small Cell Lung Cancer